Product overview
Type
Influenza, seasonal (Quadrivalent)
Commercial Name
Afluria® Quadrivalent
Manufacturer
Seqirus Limited
URL
Responsible NRA
US Food and Drug Administration- Office of Vaccine Research and Review
Country
United States of America
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
12 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton of 1 multidose vial (10 doses) [Dimensions: 3.8 x 6.0 x 3.1 cm]
Tertiary Packaging
Shipping box containing 80 vials (800 doses of 0.5mL or 1,600 doses of 0.25 mL) [Dimensions: 28.2 x 21.6 x 14.1 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.01 % w/v
Cold Chain Volume
7.06 cm3/dose (in secondary packaging)